Genetic Technologies Ltd (GTG) – Strategy, SWOT and Corporate Finance Report

Genetic Technologies Ltd (GTG) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. The company delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneType for breast cancer, a test that examines woman’s clinical risk factors with scientifically validated genetic biomarkers, to enable personalized breast cancer risk assessment and GeneType for Colorectal Cancer combines patient age, genetic markers and family history to provide more accurate assessment of colorectal cancer risk. The company serves healthcare providers and patients in the US and Australia. GTG is headquartered in Fitzroy, Victoria, Australia.

Scope

• Detailed information on Genetic Technologies Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Genetic Technologies Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Genetic Technologies Ltd including a breakdown and examination of key business segments

• News about Genetic Technologies Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Genetic Technologies Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Genetic Technologies Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Genetic Technologies Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Universal Biosensors Pty Ltd.

Sonic Healthcare Ltd

Portland Surgical Products Pty Ltd

Pharmaxis Ltd

AusBiotech Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Genetic Technologies Ltd - Key Facts

Genetic Technologies Ltd - Key Employees

Genetic Technologies Ltd - Key Employee Biographies

Genetic Technologies Ltd - Major Products and Services

Genetic Technologies Ltd - History

Genetic Technologies Ltd - Company Statement

Genetic Technologies Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Genetic Technologies Ltd - Business Description

Business Segment: AffinityDNA

Performance

Business Segment: EasyDNA

Performance

Business Segment: GeneType/ Corporate

Performance

Geographical Segment: America and Canada

Performance

Geographical Segment: Asia Pacific

Performance

Geographical Segment: Europe Middle East and Africa

Performance

Geographical Segment: Latin America

Performance

R&D Overview

Genetic Technologies Ltd - Corporate Strategy

Genetic Technologies Ltd - SWOT Analysis

SWOT Analysis - Overview

Genetic Technologies Ltd - Strengths

Genetic Technologies Ltd - Weaknesses

Genetic Technologies Ltd - Opportunities

Genetic Technologies Ltd - Threats

Genetic Technologies Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Genetic Technologies Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 28, 2023: Quarterly Activities Update: Encouraging Growth for Genetype Commercial Test Volume

Apr 28, 2023: New publication validates geneType for melanoma risk assessment

Feb 17, 2023: Genetic Technologies : Receipt of R&D tax incentive refund for geneType multi test

Feb 01, 2023: GTG to form strategic alliance with global testing leader QIAGEN

Jan 24, 2023: Genetic Technologies presented improved clinical colorectal cancer risk prediction model integrating polygenic risk at ASCOGI Cancer Symposium

Jan 24, 2023: Improved Clinical Colorectal Cancer Risk Prediction Model Integrating Polygenic Risk Presented at ASCOGI Cancer Symposium

Jan 11, 2023: Genetic Technologies provides business update

Oct 10, 2022: Genetic Technologies : Appointment of CFO and Company Secretary

Sep 29, 2022: Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer

Sep 02, 2022: Genetic Technologies provides update on US Operations and Payer Engagement

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Genetic Technologies Ltd, Key Facts

Genetic Technologies Ltd, Key Employees

Genetic Technologies Ltd, Key Employee Biographies

Genetic Technologies Ltd, Major Products and Services

Genetic Technologies Ltd, History

Genetic Technologies Ltd, Subsidiaries

Genetic Technologies Ltd, Key Competitors

Genetic Technologies Ltd, Ratios based on current share price

Genetic Technologies Ltd, Annual Ratios

Genetic Technologies Ltd, Annual Ratios (Cont…1)

Genetic Technologies Ltd, Interim Ratios

Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Genetic Technologies Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Genetic Technologies Ltd, Performance Chart (2019 – 2023)

Genetic Technologies Ltd, Ratio Charts

Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Genetic Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports